Intellia Therapeutics Inc (FRA:38I)
€ 21.68 -0.35 (-1.59%) Market Cap: 2.05 Bil Enterprise Value: 1.42 Bil PE Ratio: 0 PB Ratio: 2.15 GF Score: 56/100

Q1 2020 Intellia Therapeutics Inc Earnings Call Transcript

May 07, 2020 / 12:00PM GMT
Release Date Price: €12.05 (-2.90%)
Operator

Good morning. My name is Andrew, and I will be your conference operator today. Welcome to the Intellia Therapeutics First Quarter 2020 Financial Results Conference Call.

(Operator Instructions)

Please note, this event is being recorded. I would now like to turn the conference over to Lina Li, Associate Director of Investor Relations at Intellia.

Lina Li
Intellia Therapeutics, Inc. - Associate Director of IR

Thank you, operator. Good morning, everyone. And welcome to Intellia's First Quarter 2020 Earnings Call. Today, we are coming to you from different locations, and we ask that you please bear with us in the event we have any audio interruptions on the call.

Earlier this morning, we issued a press release outlining our progress this quarter and the topics we plan to discuss on today's call. This release can be found on the investors and media section of our website at www.intelliatx.com. This call is being broadcast live, and a replay will also be archived on our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot